6,2',4'-TrimethoxyflavoneAryl hydrocarbon receptor antagonist CAS# 720675-74-1 |
- Edoxaban tosylate monohydrate
Catalog No.:BCC1545
CAS No.:1229194-11-9
- Otamixaban
Catalog No.:BCC1827
CAS No.:193153-04-7
- Betrixaban
Catalog No.:BCC5118
CAS No.:330942-05-7
- Rivaroxaban
Catalog No.:BCC2292
CAS No.:366789-02-8
- Edoxaban
Catalog No.:BCC1543
CAS No.:480449-70-5
- Apixaban
Catalog No.:BCC2295
CAS No.:503612-47-3
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 720675-74-1 | SDF | Download SDF |
PubChem ID | 688802 | Appearance | Powder |
Formula | C18H16O5 | M.Wt | 312.32 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble to 5 mM in DMSO with gentle warming | ||
Chemical Name | 2-(2,4-dimethoxyphenyl)-6-methoxychromen-4-one | ||
SMILES | COC1=CC2=C(C=C1)OC(=CC2=O)C3=C(C=C(C=C3)OC)OC | ||
Standard InChIKey | WUWFDVDASNSUKP-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C18H16O5/c1-20-11-5-7-16-14(8-11)15(19)10-18(23-16)13-6-4-12(21-2)9-17(13)22-3/h4-10H,1-3H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Aryl hydrocarbon receptor antagonist (EC50 = 0.9 μM). Exhibits no short term agonist activity and no species or promoter dependence. |
6,2',4'-Trimethoxyflavone Dilution Calculator
6,2',4'-Trimethoxyflavone Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.2018 mL | 16.0092 mL | 32.0184 mL | 64.0369 mL | 80.0461 mL |
5 mM | 0.6404 mL | 3.2018 mL | 6.4037 mL | 12.8074 mL | 16.0092 mL |
10 mM | 0.3202 mL | 1.6009 mL | 3.2018 mL | 6.4037 mL | 8.0046 mL |
50 mM | 0.064 mL | 0.3202 mL | 0.6404 mL | 1.2807 mL | 1.6009 mL |
100 mM | 0.032 mL | 0.1601 mL | 0.3202 mL | 0.6404 mL | 0.8005 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Aryl hydrocarbon receptor antagonist (EC50 = 0.9 μM). Exhibits no short term agonist activity and no species or promoter dependence.
- Spinosin
Catalog No.:BCN1644
CAS No.:72063-39-9
- Sepinol
Catalog No.:BCN4277
CAS No.:72061-63-3
- Lochnericine
Catalog No.:BCN4595
CAS No.:72058-36-7
- NHS-LC-Biotin
Catalog No.:BCC3579
CAS No.:72040-63-2
- Henryoside
Catalog No.:BCN4276
CAS No.:72021-23-9
- 2-Geranyl-4-isobutyrylphloroglucinol
Catalog No.:BCN7170
CAS No.:72008-03-8
- Chlorquinaldol
Catalog No.:BCC4648
CAS No.:72-80-0
- Metandienone
Catalog No.:BCC9025
CAS No.:72-63-9
- 2,2-Bis(4-chlorophenyl)-1,1-dichloroethylene
Catalog No.:BCC8493
CAS No.:72-55-9
- 2,2-Bis(4-chlorophenyl)-1,1-dichloroethane
Catalog No.:BCC8492
CAS No.:72-54-8
- Alizarin
Catalog No.:BCN3479
CAS No.:72-48-0
- H-Thr-OH
Catalog No.:BCC3102
CAS No.:72-19-5
- 5(6)-Carboxyfluorescein
Catalog No.:BCC8283
CAS No.:72088-94-9
- Mastoparan X
Catalog No.:BCC5833
CAS No.:72093-22-2
- Prilocaine
Catalog No.:BCC4929
CAS No.:721-50-6
- Nerolidol
Catalog No.:BCN5459
CAS No.:7212-44-4
- b-Casomorphin (1-3)
Catalog No.:BCC1007
CAS No.:72122-59-9
- 2-Hydroxyplatyphyllide
Catalog No.:BCN7119
CAS No.:72145-19-8
- Aflatoxin B2
Catalog No.:BCC9213
CAS No.:7220-81-7
- Calcitetrol
Catalog No.:BCC1446
CAS No.:72203-93-1
- Parsonsine
Catalog No.:BCN2111
CAS No.:72213-98-0
- Echitovenidine
Catalog No.:BCN7482
CAS No.:7222-35-7
- 2-Hydroxyeupatolide
Catalog No.:BCN2490
CAS No.:72229-33-5
- 2alpha-Hydroxyeupatolide 8-O-angelate
Catalog No.:BCN7340
CAS No.:72229-39-1
Antagonism of aryl hydrocarbon receptor signaling by 6,2',4'-trimethoxyflavone.[Pubmed:19828881]
J Pharmacol Exp Ther. 2010 Jan;332(1):135-44.
The aryl hydrocarbon receptor (AHR) is regarded as an important homeostatic transcriptional regulator within physiological and pathophysiological processes, including xenobiotic metabolism, endocrine function, immunity, and cancer. Agonist activation of the AHR is considered deleterious based on toxicological evidence obtained with environmental pollutants, which mediate toxic effects through AHR. However, a multitude of plant-derived constituents, e.g., polyphenols that exhibit beneficial properties, have also been described as ligands for the AHR. It is conceivable that some of the positive aspects of such compounds can be attributed to suppression of AHR activity through antagonism. Therefore, we conducted a dioxin response element reporter-based screen to assess the AHR activity associated with a range of flavonoid compounds. Our screen identified two flavonoids (5-methoxyflavone and 7,4'-dimethoxyisoflavone) with previously unidentified AHR agonist potential. In addition, we have identified and characterized 6,2',4'-trimethoxyflavone (TMF) as an AHR ligand that possesses the characteristics of an antagonist having the capacity to compete with agonists, such as 2,3,7,8-tetrachlorodibenzo-p-dioxin and benzo[a]pyrene, thus effectively inhibiting AHR-mediated transactivation of a heterologous reporter and endogenous targets, e.g., CYP1A1, independent of cell lineage or species. Furthermore, TMF displays superior action by virtue of having no partial agonist activity, in contrast to other documented antagonists, e.g., alpha-napthoflavone, which are partial weak agonists. TMF also exhibits no species or promoter dependence with regard to AHR antagonism. TMF therefore represents an improved tool allowing for more precise dissection of AHR function in the absence of any conflicting agonist activity.